Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intestinal gel (LCIG) treatment in advanced Parkinson's disease (PD) patients under routine clinical care. METHODS: Motor fluctuations, dyskinesia, non-motor symptoms, quality of life, and safety were evaluated. Observations were fully prospective for treatment-naïve patients (60% of patients) and partially retrospective for patients with ≤12 months of pre-treatment with LCIG (40% of patients). Hours of "On" and "Off" time were assessed with a modified version of the Unified Parkinson's Disease Rating Scale part IV items 32 and 39. RESULTS: Overall, 375 patients were enrolled by 75 movement disorder centers in 18 countries and 258 patients completed the registry. At 24 months LCIG treatment led to significant reductions from baseline in "Off" time (hours/day) (mean ± SD = -4.1 ± 3.5, P < 0.001), "On" time with dyskinesia (hours/day) (-1.1 ± 4.8, P = 0.006), Non-Motor Symptom Scale total (-16.7 ± 43.2, P < 0.001) and individual domains scores, and Parkinson's Disease Questionnaire-8 item total score (-7.1 ± 21.0, P < 0.001). Adverse events deemed to have a possible/probable causal relationship to treatment drug/device were reported in 194 (54%) patients; the most frequently reported were decreased weight (6.7%), device related infections (5.9%), device dislocations (4.8%), device issues (4.8%), and polyneuropathy (4.5%). CONCLUSIONS: LCIG treatment led to sustained improvements in motor fluctuations, non-motor symptoms particularly sleep/fatigue, mood/cognition and gastrointestinal domains, as well as quality of life in advanced PD patients over 24 months. Safety events were consistent with the established safety profile of LCIG.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Olanow, C. W., Kieburtz, K., Odin, P., Espay, A. J., Standaert, D. G., Fernandez, H. H., Vanagunas, A., Othman, A. A., Widnell, K. L., Robieson, W. Z., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70293-x · Cited by 716
Self-citation
Cited by
Deuschl, G., Antonini, A., Costa, J., Śmiłowska, K., Berg, D., Corvol, J., Fabbrini, G., Ferreira, J., Foltynie, T., Mir, P., et al. (2022) · Movement Disorders · doi:10.1002/mds.29066 · Cited by 190
Self-citation
Metadata
- Authors
- Antonini, A., Poewe, W., Chaudhuri, K. R., Jech, R., Pickut, B., Pirtošek, Z., Szasz, J., Valldeoriola, F., Winkler, C., Bergmann, L., Yegin, A., Onuk, K., Barch, D., Odin, P., Amalia, E., Arnold, G., Bajenaru, O., Bergmans, B., Bjornara, K. A., Blackie, J., Bode, M., Bourgeois, P., Bohlhalter, S., Buraga, I., Burkhard, P. R., Busson, P., Calopa, M., Clausen, J., Danielsen, E. H., Defebvre, L., Delvaux, V., Dethy, S., Dietrichs, E., De Fabregues, O., Gerhard, R., Gusmaroli, G., Hahn, K., Hauptmann, B., Henriksen, T., Hernandez-Vara, J., Jeanjean, A., Kaiserova, M., Kassubek, J., Kimber, T., Konitsiotis, S., Krüger, R., Kulisevsky, J., Leenders, J., Lundqvist, C., Ory Magne, F., Marano, P., Milanov, I., Modugno, N., Misbahuddin, A., Nevrly, M., Panayiotis, Z., Pedersen, K. F., Pedersen, S. W., Perju-Dumbrava, L., Ponsen, M. M., Popescu, B. O., Rijntjes, M., Puente, V., Redecker, C., Schrader, C., Sensi, M., Simu, M., Spanaki, C., Storch, A., Storstein, A., Tomantschger, V., van der Linden, C., van Laar, T., Viallet, F., Witjas, T., Wolz, M., Zibetti, M., & Van Zandijcke, M.
- Venue
- Parkinsonism & Related Disorders
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 45
- Pages
- 13-20
- ISSN
- 1353-8020 (ISSN-L)
- OpenAlex
- W2757488384
- Cited by
- 220
- References
- 1
- FWCI
- 9.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry. https://app.cochat.ai/papers/10.1016/j.parkreldis.2017.09.018
- The paper
- Antonini, A., Poewe, W., Chaudhuri, K. R., Jech, R., Pickut, B., Pirtošek, Z., Szasz, J., Valldeoriola, F., Winkler, C., Bergmann, L., Yegin, A., Onuk, K., Barch, D., Odin, P., Amalia, E., Arnold, G., Bajenaru, O., Bergmans, B., Bjornara, K. A., . . . Van Zandijcke, M. (2017). Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry. Parkinsonism & Related Disorders. https://doi.org/10.1016/j.parkreldis.2017.09.018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.